[1] Chang W, Ye Q, Xu D, et al. Robotic versus open surgery for simultaneous resection of rectal cancer and liver metastases: a randomized controlled trial[J]. Int J Surg, 2023,109(11):3346-3353. [2] 姚鹏,柴嘉穗,潘登,等. 改良二步肝切除联合免疫靶向治疗临界可切除肝癌的临床疗效[J]. 中华消化外科杂志,2024,23(7):984-988. [3] Díaz Vico T, Granero Castro P, Alcover Navarro L, et al. Two stage hepatectomy (TSH) versus ALPPS for initially unresectable colorectal liver metastases: a systematic review and meta-analysis[J]. Eur J Surg Oncol, 2023 ,49(3):550-559. [4] Haberman D M, Andriani O C, Segaran N L, et al. Role of CT in two-stage liver surgery[J]. Radiographics, 2022,42(1):106-124. [5] Magistri P, Guidetti C, Catellani B, et al. Robotic ALPPS for primary and metastatic liver tumours: short-term outcomes versus open approach[J]. Updates Surg, 2024,76(2):435-445. [6] Loke S, Ong B D C, Ng J, et al. Safety and efficacy of minimally invasive associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a systematic review and meta-analysis[J]. Int J Surg, 2025,111(2):2283-2290. [7] Wah T M, Pech M, Thormann M, et al. A multi-centre, single arm, non-randomized, prospective European trial to evaluate the safety and efficacy of the histosonics system in the treatment of primary and metastatic liver cancers (#HOPE4LIVER)[J]. Cardiovasc Intervent Radiol, 2023,46(2):259-267. [8] Deng Q, He M, Fu C, et al. Radiofrequency ablation in the treatment of hepatocellular carcinoma[J]. Int J Hyperthermia, 2022,39(1):1052-1063. [9] 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗指南(2022年版)[J]. 中华肝脏病杂志,2022,30(4):367-388. [10] 海峡两岸医药卫生交流协会肿瘤防治专家委员会. 肝癌肝切除围手术期管理中国专家共识(2021年版)[J]. 中华肿瘤杂志,2021,43(4):414-430. [11] Xiao Y, Peng L, Xu H, et al. Mechanism of liver regeneration during ALPPS[J]. Front Cell Dev Biol,2022,8(10):916286. [12] 郑本波,刘航,黄文,等. 临界可切除肝癌行肝动脉灌注化疗联合肝动脉栓塞术转化治疗的疗效[J]. 中国普通外科杂志,2024,33(1):36-43. [13] Hotineanu A, Burgoci S, Bortǎ E. ALPPS Procedure. The new frontier in advanced liver surgery. Single centre experience and literature review[J]. Chirurgia (Bucur), 2021,116(4):409-423. [14] Wang Q, Ji Y, Brismar T B, et al. Sequential portal vein embolization and percutaneous radiofrequency ablation for future liver remnant growth: a minimally invasive alternative to ALPPS stage-1 in treatment of hepatocellular carcinoma[J]. Front Surg,2021,30(8):741352. [15] Wang Q, Chen S, Yan J, et al. Rescue radiofrequency ablation or percutaneous ethanol injection: a strategy for failed RALPPS stage-1 in patients with cirrhosis-related hepatocellular carcinoma[J]. BMC Surg, 2021,21(1):246. [16] Hu Q, Zeng Z, Zhang Y, et al. Study of ultrasound-guided percutaneous microwave ablation combined with portal vein embolization for rapid future liver remnant increase of planned hepatectomy[J]. Front Oncol, 2023,4(12):926810. [17] 孙光辉,曹峻,陈少科,等. 改良ALPPS大鼠模型安全性及有效性的评价研究[J]. 新疆医科大学学报,2022,45(9):964-968. [18] Zhang W, Zhu X, Tang Y, et al. Kupffer cells depletion alters cytokine expression and delays liver regeneration after radio-frequency-assisted liver partition with portal vein ligation[J]. Mol Immunol,2022 4(144):71-77. [19] 刘佳,刘俊,朱坪.射频消融辅助改良ALPPS术治疗老年原发性肝癌的临床效果及对术后局部复发的影响[J].中国肿瘤外科杂志,2022,14(1):89-93 [20] 陈英,王小飞,冯凯,等. 射频消融辅助的ALPPS在剩余肝体积不足肝癌患者中的应用分析[J]. 中华肝胆外科杂志,2022,28(11):812-816. |